Clinical Trials Logo

Testis Cancer clinical trials

View clinical trials related to Testis Cancer.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03880994 Completed - Clinical trials for Cognitive Impairment

Mental Health of Men Before and After Testicular Cancer Treatment

Start date: March 25, 2019
Phase:
Study type: Observational [Patient Registry]

This is a prospective observational study, that investigates men diagnosed with testicular cancer before and after treatment. The patients are included at their visit at the Fertility clinic in Horsens, where they deposit semen for cryopreservation prior to surgery and potential systemic treatment. Here the patients, who want to participate will perform a cognitive test and afterwards complete a questioner (T1). After 9 month the patients will be invited to perform the cognitive test and complete the questionnaire again (T2).

NCT ID: NCT02429466 Completed - Testicular Cancer Clinical Trials

Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors

Start date: April 27, 2015
Phase: Phase 1
Study type: Interventional

This is an open-label, single arm, Phase I dose escalation study in subjects with refractory germ cell tumor (rGCT). This phase I will evaluate the safety and efficacy of SGI-110 in combination with cisplatin in subjects with rGCT. The primary objective is to determine the maximum tolerated dose (MTD) of SGI-110 to be used prior to cisplatin. A total of 15 subjects will be enrolled in this study at the Indiana University Simon Cancer Center.